Broadwood Partners rallies opposition to STAAR Surgical-Alcon deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- US and Iran discuss phased deal to reopen Hormuz and end US blockade, sources say
Broadwood Partners Highlights Growing Opposition to STAAR Surgical’s Proposed Sale to Alcon
October 20, 2025 8:42 AM EDTLeading Proxy Advisory Firms ISS, Glass Lewis, and Egan-Jones, as well as Long-Term Shareholders Echo Broadwoods Concerns over Deeply Deficient Sale Process, Timing, and Price
Shareholders Representing More than 34% of STAARs Outstanding Common Shares Have Publicly Opposed the Transaction
Broadwood Urges All Shareholders to Vote AGAINST the Proposed Acquisition
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (Broadwood or we) today commented on the increasing public opposition to the proposed acquisition of STAAR Surgical Company (STAAR or the Company) (NASDAQ:... More
